2026 NPPES data Nephrology Physician NPI 1497783856 M.D.
Verify on CMS →

JAMES GODWIN, M.D.

Nephrology Physician in CARY, North Carolina. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
459
Medicare Part D claims · 108 beneficiaries · Nephrology Physician avg: 1K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$231.94
10 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

JAMES GODWIN, M.D. filed 459 Medicare Part D claims in 2023 as a Nephrology Physician in CARY, North Carolina, prescribing 87% generic.

459
Part D claims, 2023
87%
generic prescribing
$231.94
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JAMES GODWIN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

459 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

JAMES GODWIN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JAMES GODWIN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 06/28/2006

NPI 1497783856

Primary specialty

Nephrology Physician

Mid-sized

10,534 US NPIs in this specialty

Medicare Part D claims

459 68% vs specialty avg

2023 prescription claims

Specialty avg: 1,454

Specialty distribution in North Carolina

How Nephrology Physician compares to other specialties among North Carolina providers

North Carolina providers

Nephrology Physician share within North Carolina

1. Nephrology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Nephrology Physician share within North Carolina

Specialty board-certification context

Estimated specialty board-certified rate — Nephrology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Nephrology Physician ABMS/AOA estimate

Est. board-certified rate (Nephrology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Nephrology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JAMES GODWIN, M.D. appears in the CMS NPPES registry as a Nephrology Physician provider holding M.D. credentials at 790 SE CARY PKWY, CARY, NC, 27511, with a listed phone of (919) 231-3966. NPI 1497783856 was issued on 06/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GODWIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 459 prescription claims written by this provider, covering 108 Medicare beneficiaries and totaling roughly $38K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 5.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Nephrology Physician is a mid-sized specialty nationwide, with 10,534 enrolled providers across 55 states and an average of 1,454 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

790 SE CARY PKWY
CARY, NC 27511

Provider Details

NPI 1497783856
Specialty Nephrology Physician
Credentials M.D.
Gender Male
NPI Issued 06/28/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JAMES GODWIN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$232

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

JAMES GODWIN, M.D. — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 459 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

459
Total Claims
$38K
Total Drug Cost
108
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
939
Total Day Supply
26,740
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$26K
Generic Drug Cost
$12K
Opioid Claims
27 (5.9% rate)
Antibiotic Claims
17

Patient Demographics

Average Patient Age
73.4 years
Avg HCC Risk Score
3.70
Gender Split
46% female / 54% male
Age Distribution
<65: 14, 65-74: 43, 75-84: 34, 85+: 17

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What JAMES GODWIN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Tamsulosin Hcl
28
Amlodipine Besylate
27
Febuxostat
24
Torsemide
22
Prednisone
21
Furosemide
17
Hydromorphone Hcl
17
Allopurinol
13
Hydralazine Hcl
12
Estradiol
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Nephrology Physician Overview

How JAMES GODWIN, M.D. fits within the Nephrology Physician landscape nationally.

10,534
Nephrology Physician Providers in US
55
States with Nephrology Physician
1,454
Avg Claims per Provider

JAMES GODWIN, M.D.'s 459 claims are below the specialty average of 1,454.

Nearby Nephrology Physician Providers in North Carolina

Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as GODWIN.

Compare Nephrology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JAMES GODWIN, M.D.'s specialty?
JAMES GODWIN, M.D. specializes in Nephrology Physician and practices in CARY, North Carolina. Credentials: M.D..
How much does JAMES GODWIN, M.D. prescribe under Medicare Part D?
In 2023, JAMES GODWIN, M.D. wrote 459 Medicare Part D claims totaling $38K in drug costs for 108 beneficiaries.
Where is JAMES GODWIN, M.D. located?
JAMES GODWIN, M.D. is located at 790 SE CARY PKWY, CARY, NC, 27511. Phone: (919) 231-3966.
What is JAMES GODWIN, M.D.'s NPI number?
JAMES GODWIN, M.D.'s National Provider Identifier (NPI) is 1497783856, issued on 06/28/2006.
Does JAMES GODWIN, M.D. prescribe more brand-name or generic drugs?
JAMES GODWIN, M.D.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $26K in brand drug costs.
Does JAMES GODWIN, M.D. prescribe opioids?
Yes, JAMES GODWIN, M.D. had 27 opioid claims in 2023 with an opioid prescribing rate of 5.9%.
How many Nephrology Physician providers are there in the US?
There are 10,534 Nephrology Physician providers across 55 states in the US. The average Nephrology Physician provider writes 1,454 Medicare Part D claims per year.
What drugs does JAMES GODWIN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JAMES GODWIN, M.D.'s most frequently prescribed drugs include Tamsulosin Hcl, Amlodipine Besylate, Febuxostat. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JAMES GODWIN, M.D. accept Medicare?
JAMES GODWIN, M.D. appears in CMS Medicare data with 459 Part D claims and 108 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JAMES GODWIN, M.D.'s credentials?
JAMES GODWIN, M.D.'s NPI is 1497783856 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology